女性稳定缺血性心脏病评估中的心肌灌注成像:证据现状与临床推荐
美国核心脏病学会更新的共识声明,聚焦SPECT和PET心肌灌注成像在女性稳定缺血性心脏病评估中的证据。SPECT和PET心肌灌注成像可有效对女性进行风险分层,PET测定的冠状动脉血流储备可改善风险检出,包括非阻塞性冠状动脉疾病和冠状动脉微血管功能障碍女性。声明还讨论了辐射剂量降低策略和候选者选择。
要点
- SPECT和PET心肌灌注成像可有效对稳定缺血性心脏病女性进行风险分层。
- PET测定的冠状动脉血流储备可改善风险检出,包括非阻塞性冠状动脉疾病和冠状动脉微血管功能障碍女性。
- 应尽可能对所有接受心肌灌注成像的女性统一应用辐射剂量降低策略。
核心结论
- SPECT和PET心肌灌注成像可有效对稳定缺血性心脏病女性进行风险分层。
- PET测定的冠状动脉血流储备可改善风险检出,包括非阻塞性冠状动脉疾病和冠状动脉微血管功能障碍女性。
- 应尽可能对所有接受心肌灌注成像的女性统一应用辐射剂量降低策略,包括负荷-only成像、固态探测器SPECT和PET的超低剂量方案。
研究设计与样本
- 美国核心脏病学会更新的共识声明,基于证据基础,强调SPECT和PET在女性稳定缺血性心脏病临床评估中的新进展。
临床应用与阅片要点
- 声明讨论了应激心肌灌注成像的适当候选者选择以及心肌灌注成像后指南导向药物治疗和/或侵入性冠状动脉造影的指征。
- 声明强调女性患者中随机对照和比较试验数据的迫切需求。
局限性
- 声明强调女性患者中随机对照和比较试验数据的迫切需求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
This document from the American Society of Nuclear Cardiology represents an updated consensus statement on the evidence base of stress myocardial perfusion imaging (MPI), emphasizing new developments in single-photon emission tomography (SPECT) and positron emission tomography (PET) in the clinical evaluation of women presenting with symptoms of stable ischemic heart disease (SIHD). The clinical evaluation of symptomatic women is challenging due to their varying clinical presentation, clinical risk factor burden, high degree of comorbidity, and increased risk of major ischemic heart disease events. Evidence is substantial that both SPECT and PET MPI effectively risk stratify women with SIHD. The addition of coronary flow reserve (CFR) with PET improves risk detection, including for women with nonobstructive coronary artery disease and coronary microvascular dysfunction. With the advent of PET with computed tomography (CT), multiparametric imaging approaches may enable integration of MPI and CFR with CT visualization of anatomical atherosclerotic plaque to uniquely identify at-risk women. Radiation dose-reduction strategies, including the use of ultra-low-dose protocols involving stress-only imaging, solid-state detector SPECT, and PET, should be uniformly applied whenever possible to all women undergoing MPI. Appropriate candidate selection for stress MPI and for post-MPI indications for guideline-directed medical therapy and/or invasive coronary angiography are discussed in this statement. The critical need for randomized and comparative trial data in female patients is also emphasized.
引用
- Taqueti VR, Dorbala S, Wolinsky D, et al. Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease-state-of-the-evidence and clinical recommendations. J Nucl Cardiol. 2017. PMID: 28585034. doi:10.1007/s12350-017-0926-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。